Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study

PURPOSE: Infliximab is currently used for the treatment of active Crohn's disease (CD). We aimed to assess the efficacy and safety of infliximab therapy and to determine the predictors of response in Korean patients with CD. MATERIALS AND METHODS: A total of 317 patients who received at least o...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Chang Hwan, Song, In Do, Kim, Young-Ho, Koo, Ja Seol, Kim, You Sun, Kim, Joo Sung, Kim, Nayoung, Kim, Eun Soo, Kim, Jae Hak, Kim, Ji Won, Kim, Tae Oh, Kim, Hyun Soo, Kim, Hyo Jong, Park, Young Sook, Park, Dong Il, Park, Soo Jung, Song, Hyun Joo, Shin, Sung Jae, Yang, Suk-Kyun, Ye, Byong Duk, Lee, Kang-Moon, Lee, Bo In, Lee, Sun-Young, Lee, Chang Kyun, Im, Jong Pil, Jang, Byung Ik, Jeon, Tae Joo, Cho, Yu Kyung, Chang, Sae Kyung, Jeon, Seong Ran, Jung, Sung-Ae, Jeen, Yoon Tae, Cha, Jae Myung, Han, Dong Soo, Kim, Won Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011269/
https://www.ncbi.nlm.nih.gov/pubmed/27593865
http://dx.doi.org/10.3349/ymj.2016.57.6.1376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011269/
https://www.ncbi.nlm.nih.gov/pubmed/27593865
http://dx.doi.org/10.3349/ymj.2016.57.6.1376

Ejemplares similares